Perioperative Methotrexate, Vinblastine, Doxorubicin and Cisplatin (M-VAC) for Poor Risk Transitional Cell Carcinoma of the Bladder: An Eastern Cooperative Oncology Group Pilot Study

1990 ◽  
Vol 144 (5) ◽  
pp. 1123-1126 ◽  
Author(s):  
Robert Dreicer ◽  
Edward M. Messing ◽  
Patrick J. Loehrer ◽  
Donald L. Trump
Keyword(s):  
Pilot Study ◽  
Transitional Cell Carcinoma ◽  
Cell Carcinoma ◽  
Transitional Cell ◽  
Eastern Cooperative Oncology Group ◽  
Oncology Group ◽  
Poor Risk ◽  
Carcinoma Of The Bladder

Intravesical Gemcitabine in BCG-Refractory T1G3 Transitional Cell Carcinoma of the Bladder: A Pilot Study

2006 ◽  
Vol 76 (2) ◽  
pp. 106-111 ◽  
Author(s):  
Mauro Gacci ◽  
Riccardo Bartoletti ◽  
Tommaso Cai ◽  
Stefano Nerozzi ◽  
Novello Pinzi ◽  
...  
Keyword(s):  
Pilot Study ◽  
Transitional Cell Carcinoma ◽  
Cell Carcinoma ◽  
Transitional Cell ◽  
Carcinoma Of The Bladder

Treatment of Transitional Cell Carcinoma of the Bladder With Intravesical Interleukin-2: A Pilot Study

1993 ◽  
Vol 8 (3) ◽  
pp. 223-227 ◽  
Author(s):  
Leonard G. Gomella ◽  
David E. McGinnis ◽  
Edmund C. Lattime ◽  
Karen Butler ◽  
Marianne Baltish ◽  
...  
Keyword(s):  
Pilot Study ◽  
Transitional Cell Carcinoma ◽  
Cell Carcinoma ◽  
Transitional Cell ◽  
Interleukin 2 ◽  
Carcinoma Of The Bladder

969: Intravesical Antisense G3139 Efficacy in Transitional Cell Carcinoma of the Bladder

2004 ◽  
Vol 171 (4S) ◽  
pp. 257-257
Author(s):  
Sam B. Gray ◽  
Brian J. Duggan ◽  
Perry Maxwell ◽  
Ken Arthur ◽  
Neil Anderson ◽  
...  
Keyword(s):  
Transitional Cell Carcinoma ◽  
Cell Carcinoma ◽  
Transitional Cell ◽  
Carcinoma Of The Bladder
Sign in / Sign up

Export Citation Format

Share Document